Neuragen PN

Product NDC: 15377-002
11-digit product format: 153770002
Labeler code: 15377
Product ID: 15377-002_9162ac36-62de-4d2c-bf16-c84045016264
Type: HUMAN OTC DRUG
Nonproprietary name: Aconitum napellus, Hypericum perforatum, Lycopodium clavatum, Phosphorus, Rhus toxicodendron, Secale cornutum
Dosage form: SOLUTION
Route: TOPICAL
Labeler: Origin Biomed Inc
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2005-08-01
Marketing end: 0000-00-00
Substance: HYPERICUM PERFORATUM; ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM
Active strength: 12 [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	15377-002		D	Discontinued by firm	2026-10-05
excluded product	product	15377-002		I	Inactivated by FDA	2026-10-05
excluded package	package	15377-002	15377-002-04	D	Discontinued by firm	2026-10-05
excluded package	package	15377-002	15377-002-05	I	Inactivated by FDA	2026-10-05
excluded package	package	15377-002	15377-002-15	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 90 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	15377-002-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	15377-002-15	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	15377-002-04	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	15377-002-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	15377-002-15	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	15377-002-04	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	15377-002-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	15377-002-15	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	15377-002-04	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	15377-002-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	15377-002-15	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	15377-002-04	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	15377-002-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	15377-002-15	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	15377-002-04	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	15377-002-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	15377-002-15	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	15377-002-04	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	15377-002-05	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	15377-002-15	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	15377-002-04	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	15377-002-05	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	15377-002-15	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	15377-002-04	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	15377-002-05	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	15377-002-15	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	15377-002-04	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	15377-002-05	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	15377-002-15	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	15377-002-04	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	15377-002-05	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	15377-002-15	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	15377-002-04	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	15377-002-05	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	15377-002-15	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	15377-002-04	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
15377-002-05	2019-11-27	C162847	48780-1	9855e2a2-37f8-60a7-e053-dbdaa90a05bd	Drug Facts
15377-002-15	2019-11-27	C162847	48780-1	9855e2a2-37f8-60a7-e053-dbdaa90a05bd	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
15377-002-05	Neuragen PN	5 mL in 1 BOTTLE	SOLUTION	5	16
15377-002-05	Neuragen PN	1 in 1 CARTON	SOLUTION	1	16
15377-002-15	Neuragen PN	15 mL in 1 BOTTLE	SOLUTION	15	16
15377-002-15	Neuragen PN	1 in 1 CARTON	SOLUTION	1	16

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
CLAVICEPS PURPUREA SCLEROTIUM	ACTIVE INGREDIENT	01G9XEA93N	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
HYPERICUM PERFORATUM	ACTIVE INGREDIENT	XK4IUX8MNB	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
LYCOPODIUM CLAVATUM SPORE	ACTIVE INGREDIENT	C88X29Y479	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
PHOSPHORUS	ACTIVE INGREDIENT	27YLU75U4W	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
TOXICODENDRON PUBESCENS LEAF	ACTIVE INGREDIENT	6IO182RP7A	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
CLAVICEPS PURPUREA SCLEROTIUM	ACTIVE MOIETY	01G9XEA93N	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
HYPERICUM PERFORATUM	ACTIVE MOIETY	XK4IUX8MNB	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
LYCOPODIUM CLAVATUM SPORE	ACTIVE MOIETY	C88X29Y479	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
PHOSPHORUS	ACTIVE MOIETY	27YLU75U4W	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
TOXICODENDRON PUBESCENS LEAF	ACTIVE MOIETY	6IO182RP7A	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
BERGAMOT OIL	INACTIVE INGREDIENT	39W1PKE3JI	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
EUCALYPTUS OIL	INACTIVE INGREDIENT	2R04ONI662	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
FRANKINCENSE OIL	INACTIVE INGREDIENT	67ZYA5T02K	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
GERANIUM OIL, ALGERIAN TYPE	INACTIVE INGREDIENT	5Q1I94P4WG	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
LAVENDER OIL	INACTIVE INGREDIENT	ZBP1YXW0H8	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
MYRRH OIL	INACTIVE INGREDIENT	H74221J5J4	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16
TEA TREE OIL	INACTIVE INGREDIENT	VIF565UC2G	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
15377-002	NEURAGEN PN (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOXICODENDRON, SECALE CORNUTUM) SOLUTION [ORIGIN BIOMED INC]	16	Legacy NDC, 4 package rows	20140923_bb55275f-cc52-4f61-bc08-411a5c2554ea.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
XK4IUX8MNB	HYPERICUM PERFORATUM		HYPERICUM PERFORATUM
U0NQ8555JD	ACONITUM NAPELLUS		ACONITUM NAPELLUS
C88X29Y479	LYCOPODIUM CLAVATUM SPORE	8023-70-9	LYCOPODIUM CLAVATUM SPORE
27YLU75U4W	PHOSPHORUS	7723-14-0	PHOSPHORUS
6IO182RP7A	TOXICODENDRON PUBESCENS LEAF		TOXICODENDRON PUBESCENS LEAF
01G9XEA93N	CLAVICEPS PURPUREA SCLEROTIUM		CLAVICEPS PURPUREA SCLEROTIUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
15377-002-05	15377000205	5 mL in 1 BOTTLE	5 ml	Historical
15377-002-15	15377000215	15 mL in 1 BOTTLE	15 ml	Historical